| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Activating T-lymphocyte using human dendritic cells for antigen presentation; in vitro or in vivo to prime or reprime immune response, e.g. for treating or preventing e.g. HIV virus, cancer, etc.
|
|
|
1994
|
12 |
9 |
p. 864-
1 p.
|
article
|
| 2 |
A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees
|
Crowe Jr, James E.
|
|
1994
|
12 |
9 |
p. 783-790
8 p.
|
article
|
| 3 |
Analysis of epitopic residues introduced into the hybrid peptide vaccines prepared according to the cassette theory
|
Naruse, Hirohito
|
|
1994
|
12 |
9 |
p. 776-782
7 p.
|
article
|
| 4 |
Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines
|
Mumford, J.A.
|
|
1994
|
12 |
9 |
p. 857-863
7 p.
|
article
|
| 5 |
Characterization of binding and TNF-α-inducing ability of chitosans on monocytes: the involvement of CD14
|
Otterlei, Marit
|
|
1994
|
12 |
9 |
p. 825-832
8 p.
|
article
|
| 6 |
Comparison of structural proteins among antigenically different Japanese encephalitis virus strains
|
Hasegawa, Hitoshi
|
|
1994
|
12 |
9 |
p. 841-844
4 p.
|
article
|
| 7 |
Construction of a synthetic immunogen: use of the natural immunomodulator polytuftsin in malaria vaccines against RESA antigen of Plasmodium falciparum
|
Pawan, K.
|
|
1994
|
12 |
9 |
p. 819-824
6 p.
|
article
|
| 8 |
Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines
|
Leroux-Roels, Geert
|
|
1994
|
12 |
9 |
p. 812-818
7 p.
|
article
|
| 9 |
Deleterious effect of thimerosal on the potency of inactivated poliovirus vaccine
|
Sawyer, Leigh A.
|
|
1994
|
12 |
9 |
p. 851-856
6 p.
|
article
|
| 10 |
Effective vaccination of cattle using the virion G protein of bovine ephemeral fever virus as an antigen
|
Uren, M.F.
|
|
1994
|
12 |
9 |
p. 845-852
8 p.
|
article
|
| 11 |
Immediate-early herpes simplex virus-2 protein ICP27; gene cloning and expression using a bacterium host, vaccinia virus vector or herpes simplex virus light particle, for use as a recombinant vaccine
|
|
|
1994
|
12 |
9 |
p. 864-
1 p.
|
article
|
| 12 |
Immune responses and protective effect in mice vaccinated orally with surface sporozoite protein of Eimeria falciformis in ISCOMs
|
Kazanji, Mirdad
|
|
1994
|
12 |
9 |
p. 798-804
7 p.
|
article
|
| 13 |
Increased encapsulation and virulence of Francisella tularensis live vaccine strain (LVS) by subculturing on synthetic medium
|
Cherwonogrodzky, John W.
|
|
1994
|
12 |
9 |
p. 773-775
3 p.
|
article
|
| 14 |
Influence of smoking on immunological responses to hepatitis B vaccine
|
Winter, Ann P.
|
|
1994
|
12 |
9 |
p. 771-772
2 p.
|
article
|
| 15 |
Influence of strain viability and antigen dose on the use of attenuated mutants of Salmonella as vaccine carriers
|
Cárdenas, Lucia
|
|
1994
|
12 |
9 |
p. 833-840
8 p.
|
article
|
| 16 |
Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection
|
Roy, Polly
|
|
1994
|
12 |
9 |
p. 805-811
7 p.
|
article
|
| 17 |
New Trypanosoma cruzi immunogen peptide; use as a Chagas disease recombinant vaccine and diagnostic agent; DNA probe, polymerase chain reaction DNA primer and monoclonal antibody production
|
|
|
1994
|
12 |
9 |
p. 864-
1 p.
|
article
|
| 18 |
Recombinant vaccine containing mutant or wild-type p53 protein; gene cloning and surface display on Mycobacterium bovis BCG, dendritic cell, macrophage or monocyte for use as an antitumour agent
|
|
|
1994
|
12 |
9 |
p. 864-
1 p.
|
article
|
| 19 |
Selective induction of protection against influenza virus infection in mice by a lipid—peptide conjugate delivered in liposomes
|
Friede, M.
|
|
1994
|
12 |
9 |
p. 791-797
7 p.
|
article
|
| 20 |
Target antigen, especially P28, for blocking transmission of antibodies of malaria parasite; Plasmodium gallinaceum recombinant Pgs28 protein production, recombinant virus-based recombinant vaccine for use in fowl protection
|
|
|
1994
|
12 |
9 |
p. 864-
1 p.
|
article
|
Journal description